Avalyn Pharma Inc. Common Stock (AVLN) vs STAAR Surgical Company (STAA)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and STAAR Surgical Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Avalyn Pharma Inc. Common Stock logo
AVLN
Avalyn Pharma Inc. Common Stock
$1.13B
$25.44HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
STAAR Surgical Company logo
STAA
STAAR Surgical Company
$1.11B
$22.24HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

Total return — AVLN vs STAA

growth of $100 · dividends reinvested · last 1y
AVLN -8.3% (-8.3%/yr)STAA -9.1% (-9.1%/yr)AVLN compounded faster over this window
8090100110120130Start $100$92$91
AVLN STAA

AVLN vs STAA: by the numbers

  • •AVLN is the larger company ($1.13B vs $1.11B market cap).
  • •STAA is profitable (1.13% net margin) while AVLN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVLNSTAA
P/E ratioN/A278.01
Forward P/EN/A76.62
P/S ratioN/A3.26
P/B ratio2.833.03
EV / EBITDAN/A22.57

Profitability

MetricAVLNSTAA
Gross margin0.00%76.23%
Operating margin0.00%-19.19%
Net margin0.00%1.13%
ROEN/A1.05%
ROIC-67.73%4.80%

Growth (annualized)

MetricAVLNSTAA
Revenue CAGR (5Y)N/A10.49%
Total return CAGR (5Y)N/A-28.41%

Frequently asked

Is AVLN or STAA more profitable?
STAA runs the higher net margin — AVLN at 0.00% versus STAA at 1.13%.

Go deeper

Full AVLN analysisFull STAA analysisInteractive comparison tool

Dig into the metrics

STAAR Surgical P/E ratioAvalyn Pharma Inc. Common Stock ROESTAAR Surgical ROEAvalyn Pharma Inc. Common Stock operating marginSTAAR Surgical operating marginAvalyn Pharma Inc. Common Stock revenue growthSTAAR Surgical revenue growthAvalyn Pharma Inc. Common Stock free cash flowSTAAR Surgical free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.